MONOCLONAL ANTIBODY TREATMENT FOR COVID-19
OFFICE IS ADMINISTERING MONOCLONAL ANTIBODY TREATMENT TO THOSE WITH CLOSE CONTACT AND RISK OF SEVERE DISEASE AS WELL AS THOSE WITH EARLY STAGE COVID INFECTION. LIMITED AVAILABILITY.
Sep 29th, 2021